ArticleCureus2025
Giant Retroperitoneal Schwannoma: Case Report and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retroperitoneal schwannomas are rare benign tumors of peripheral nerve sheath origin. We report a 72-year-old woman presenting with abdominal pain, altered bowel habits, and intermittent fever. CT imaging revealed a large (83 × 83 × 104 mm), well-circumscribed retroperitoneal mass with calcifications and heterogeneous enhancement, without invasion of adjacent structures. Following multidisciplinary discussion among thoracic surgery, medical oncology, pathology, and radiation oncology, a midline laparotomy was performed, and the tumor was completely excised. Histology demonstrated Antoni A and B areas, cystic degeneration, and focal palisading. Immunohistochemistry was positive for SOX10 and negative for CD34, DOG1, and desmin, confirming schwannoma. The postoperative course was uneventful, and the patient was discharged on day 14. We also conducted a focused review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.